An estimated 65 percent of the United States prison population has an active substance use disorder (SUD). Providing comprehensive substance use treatment to incarcerated individuals has been shown to reduce both drug use and crime upon release. Treatment is a critical intervention to prevent opioid overdose deaths, which the CDC estimates increased by 15.4 percent, from 70,029 in 2020 to approximately 80,816 in 2021. Medications like methadone, buprenorphine, and naltrexone are an important part of a comprehensive approach to addressing opioid use disorder (OUD).
Avanti Adhia, ScD, previously a Postdoctoral Scholar at the Harborview Injury Prevention and Research Center and now an Assistant Professor at the University of Washington, recently published research in JAMA Pediatrics. It explores how US states are actively seeking strategies to prevent and address teen dating violence (TDV) in schools, including enactment and implementation of TDV laws.
Section 340B of the Public Health Service Act requires that pharmaceutical manufacturers give discounts on specified outpatient drugs to certain covered entities who typically serve low-income or otherwise underserved patients, including hospitals and clinics.
As a federal program to serve meals to all U.S. public school students during the COVID-19 pandemic ends on June 30, the consequences of unpaid school meal debt will resurface for the millions of students nationwide facing food insecurity.
Welcome to the blog! Twelve years into our Center’s lifetime, we decided it was time to put pen to paper, or rather, fingers to keyboard, and create a place where we can dive more deeply into topics and issues related to legal epidemiology, the Center and its work, and connect to the people working to establish the evidence and bring it to bear to improve public health, wellbeing and equity.